Table 1.
Variable | Value (%) |
Mean age, y | 62 |
Sex | |
Male | 21 (72) |
Female | 8 (28) |
ECOG performance status | |
0 | 17 (59) |
1 | 12 (41) |
M stage | |
M1a | 2 (7) |
M1b | 6 (21) |
M1c | 21 (72) |
Prior lines of systemic therapy for metastatic disease | |
1 | 28 (97) |
2 | 1 (3) |
Ipilimumab cycles | |
4 | 23 (79) |
3 | 3 (10) |
2 | 3 (10) |
1 | 0 |
ECOG, Eastern Cooperative Oncology Group.